Medical Director

Dr. Jed Kaminetsky, M.D.


Dr. Jed Kaminetsky, M.D. is a Medical Director at Manhattan Medical Research, a Clinical Assistant Professor at New York University Medical Center, Associate medical Director of Gramercy Surgical Centre, and is a practicing urologist with University Urology Associates, one of the largest urologic practices in the New York City metropolitan area. He is a board certified urologist and is highly skilled in treating all urologic disorders, performing minimally invasive prostate surgeries and penile implants. Dr. Kaminetsky’s academic interests include the study of both male and female sexual dysfunction, which has led him to become a national and world thought leader.

Dr. Kaminetsky’s work has been published in several journals which led to a nationwide recognition and development of various treatment schemes for patients with sexual, erectile dysfunction and androgen deficiency. Moreover, Dr. Kaminetsky is an experienced principal investigator who participates in national research studies that explore pharmacologic and diagnostic techniques for various urologic disorders. He is currently conducting studies addressing premature ejaculation, ED, male and female sexual dysfunction, BPH, prostate cancer, bladder cancer, voiding dysfunction, and hypogonadism. His hospital appointments include New York University Medical Center, New York Downtown Medical Center. Dr. Kaminetsky has been consulting for several pharmaceutical companies including Slate, Pfizer, Auxilium, Lilly, GlaxoSmithKline and American Medical Systems.

Clinical Research Manager

Michael Yang


Michael Yang is the Clinical Research Manager at Integrated Medical Professionals, an affiliate of Solaris Health. He earned his degree from Cornell University in 2012 and subsequently joined Dr. Jed Kaminetsky’s clinical research team at Manhattan Medical Research Practice.
During his tenure there, Michael conducted research studies across a diverse range of indications, including hypogonadism, benign prostatic hyperplasia, type 2 diabetes, osteoarthritis, and motion sickness. His expertise encompasses all aspects of site-level clinical research operations, from study initiation to patient enrollment.
Since joining Integrated Medical Professionals in 2023, Michael has been instrumental in expanding patient access to clinical research throughout the greater New York area.